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SUMMARY
Microvascular damage and a decrease in peripheral blood perfusion are typical features of systemic sclerosis 
(SSc) with serious clinical implications, not only for a very early diagnosis, but also for disease progression.
Nailfold videocapillaroscopy is a validated and safe imaging technique able to detect peripheral capillary mor-
phology, as well as to classify and to score any nailfold abnormalities into different microangiopathy patterns. 
Capillaroscopic analysis is now included in the ACR/EULAR classification criteria for SSc. 
The decrease in peripheral blood perfusion is usually associated with microvascular damage in SSc, which may 
be studied by different methods. Several of these make use of safe laser technologies.
This paper focuses on these new clinical aspects to assess SSc microvascular impairment. 
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n	 INTRODUCION
Microvascular changes, characterized by structural and functional abnor-
malities of the microcirculation, play a 
central role in the pathogenesis of systemic 
sclerosis (SSc). Nailfold videocapillaros-
copy (NVC) represents a validated, non-
invasive, safe, inexpensive, reliable and 
reproducible method for the evaluation 
of the structural changes that occur in the 
peripheral microcirculation in SSc (1-4). 
Since microvascular damage and dysfunc-
tion are early markers of SSc and are clini-
cally mirrored by secondary Raynaud’s 
phenomenon (RP), the diagnostic, prog-
nostic and therapeutic implications of mi-
crovessel morphological analysis by NVC 
allows for the best clinical management. 
RP is often the earliest clinical symptom of 
digital microcirculatory damage and can be 
considered one of the risk factors for the 
development of a connective tissue disease. 
NVC detects and quantifies the microvas-
cular changes that characterize secondary 
RP (1, 2, 5, 6). It also distinguishes second-
ary RP from both primary RP and healthy 
subjects, identifies morphological patterns 
specific to various SSc microangiopathy 
stages (Early, Active and Late patterns) and 
allows for the calculation of the microan-
giopathy evolution score (MES) to follow 
disease evolution (4-8).
Although NVC cannot measure blood per-
fusion under standard conditions, assess-
ment of blood perfusion in SSc may be 
performed by different laser techniques (9-
11). The use of NVC in combination with 
laser equipment provides a morphological 
and functional assessment of the peripheral 
microcirculation that is a must for diagno-
sis, prognosis and therapy in SSc patients.
n	 THE PERFORMANCE 
OF NAILFOLD 
VIDEOCAPILLAROSCOPY
Patients affected by RP represent a diagnos-
tic challenge as there is a broad possibility 
of differential diagnosis. They represent the 
main indication for NVC, as the technique 
distinguishes primary from secondary RP. 
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ing both afferent and efferent branches). A 
recent study demonstrated that dilations in 
a capillary diameter of >30 micrometers at 
the level of arterial and/or venous branches 
were significantly expressed in those sub-
jects with primary RP that later developed 
secondary RP, associated with SSc (mean 
follow-up 3.56 years) (13). Furthermore, 
the observation of abnormal capillary di-
lations in primary RP subjects should be 
taken as a possible very early NVC sign of 
transition towards the Early scleroderma 
pattern of microangiopathy (13).
Three different capillary morphologies 
may be observed in normal capillaries: ste-
reotype hairpin shapes (present in 50% of 
healthy subjects); nonspecific variations 
like tortuosities (40% of controls); cross-
ing capillaries (8% of controls) (14). 
Another study reported that capillary 
branching (78%), meandering capillar-
ies (94%), tortuous loops (64%), micro-
haemorrhages (25%) and apical dilatations 
(19%) may also be found in normal sub-
jects, even if abnormal shapes usually oc-
cur with a low prevalence (15). These vari-
ations could be influenced by the subjects’ 
profession, trauma, age, onychophagy, 
manicures, exposure to chemical substanc-
es and/or individual physiological variabil-
ity (1-3, 14).
The subpapillary venous plexus visibility 
and the presence of oedema are considered 
non-specific findings that are not of univo-
cal interpretation (1-3, 12). 
Although nailfold capillaries are frequent-
ly normal in primary RP, capillaries with 
efferent branch enlargement or tortuous 
capillaries may be observed in this clini-
cal situation. Conversely, secondary RP 
is characterized by morphological signs 
that represent the microvascular damage, 
including giant capillaries, microhaemor-
rhages, capillary loss, the presence of avas-
cular areas and angiogenesis.
Several sequential capillaroscopic changes 
are typical of the microvascular involve-
ment observed in more than 95% of SSc pa-
tients, and have been described by the term 
scleroderma-pattern (1-3, 12). The NVC 
technique identifies those capillary patterns 
that have the morphological features of the 
Videocapillaroscopy is a combination of 
an optical microscope (best lens magnifica-
tion 200x) and a digital video camera. The 
patient under investigation should initially 
remain seated in an acclimatized room for 
15-20 min, with a set temperature of about 
22-23°C. A drop of immersion (cedar) oil 
is placed onto the cuticle of the fingers to 
be analysed in order to reduce any refrac-
tive defects and improve capillary visual-
ization (3, 12). 
The morphology of nailfold dermal capil-
laries is assessed by NVC at the level of 
the periungual region from the 2nd to the 5th 
finger (excluding the thumb, due to a lower 
transparency caused by the nail width and 
the absence of a distal phalanx) of both 
hands, as the capillaries run parallel to 
the skin surface in this region (3, 12). The 
qualitative NVC assessment of the capillar-
ies in this region can distinguish a normal 
pattern from an abnormal one.
Useful capillaroscopic parameters are: 
capillary density, capillary morphology, 
number of capillaries inside each dermal 
papilla, the disposition of the capillaries in 
the nailfold bed, the occurrence of ramifi-
cations and presence of haemorrhages and/
or haemosiderin deposit, skin transparency, 
visibility and morphology of the subpapil-
lary venous plexus (3, 12).
The normal range of nailfold capillaries 
density is 9-12 capillaries per linear mil-
limetre. The number of capillaries may 
be slightly less in the early phase of SSc, 
whilst the progressive capillary desertifica-
tion is a diagnostic feature of advanced SSc 
microangiopathy (2, 12). In normal sub-
jects the capillaries are parallel to one other 
in their normal disposition, in the number 
of one (rarely two) per dermal papilla, 
and are perpendicularly oriented towards 
the nailfold. A qualitative assessment of a 
normal capillaroscopic pattern is charac-
terized by a homogeneous distribution of 
hairpin-shaped capillaries with a comb-like 
structure. The capillary normal caliber is 
usually <20 μm.
A capillary is defined as ectasic when dilat-
ed at ≥20 μm (but <50 μm), whilst a giant 
capillary is defined as a vessel with a homo-
geneous dilation exceeding 50 μm (involv-
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scleroderma-pattern of microangiopathy. 
However, these may be observed not only 
in SSc, but also in mixed connective tissue 
disease, dermatomyositis and, less frequent-
ly, in undifferentiated connective tissue dis-
eases as well as in lupus erythematosus (1-
3, 12). Indeed, specific capillaroscopic pat-
terns have been described only in systemic 
sclerosis (1-3, 12, 16, 17).
A recent study by Cutolo et al. on a large 
cohort demonstrated that almost 16% of 
patients initially diagnosed as being affect-
ed by RP with negative NVC may transit 
to secondary RP over an average follow-
up of 4.4 years (16). Primary RP patients 
with non-specific nailfold capillary altera-
tions (dilations of capillary diameter >30 
micrometer at the level of arterial branch, 
microhaemorrhages, reduction of capil-
laries number <9) at first NVC evaluation 
should be closely monitored at least every 
six months, as they run a higher risk of 
transition to secondary RP (2, 13, 16).
n	 THE NAILFOLD 
VIDEOCAPILLAROSCOPIC 
SCLERODERMA-PATTERNS
The first modern interpretation of the mi-
crovascular alterations in SSc was given by 
Maricq et al. in 1980, using the wide-field 
microscopy technique, describing it as a 
scleroderma-type capillaroscopic pattern 
(18). This classification was later revised 
by Cutolo et al. in 2000, when they intro-
duced a new concept on the basis of the 
selected microvascular characteristics of 
disease progression. The microvascular le-
sions detected by NVC in SSc patients fol-
low three clearly distinct patterns that dif-
fer from the normal aspect and reflect vari-
ous phases of capillary changes. They have 
an evolutive trend from the first (Early), to 
the second (Active), until the third (Late) 
microangiopathy capillaroscopic patterns 
(1-3, 12, 19, 20). Each one is distinguished 
by typical and univocal capillaroscopic ab-
normalities and correlates with the disease 
duration and autoantibody profile (20-24).
The Early NVC scleroderma pattern is the 
most significant pattern, as it affords an 
early SSc and scleroderma-spectrum dis-
ease diagnosis. It is defined as the combi-
nation of a few enlarged/giant capillaries, 
a few capillary microhaemorrhages, a rel-
atively well preserved capillary distribu-
tion and no evident or minimal capillary 
loss (Figure 1). The Active NVC sclero-
derma pattern features frequent giant cap-
illaries, frequent capillary microhaemor-
rhages, a moderate capillary loss, mild 
disorganization of the capillary architec-
ture and absent or mild ramified capillar-
ies (Figure 1). 
Microhaemorrhages may be detected in 
the Early and Active phase of SSc micro-
angiopathy and are associated with early 
vascular damage. Indeed, their presence 
represents a transition phase between giant 
capillaries and the subsequent loss of cap-
illaries. However, microhaemorrhages are 
not specific only for the scleroderma spec-
trum disorders and may be found in other 
connective tissue diseases, such as system-
ic lupus erythematosus or antiphospholipid 
syndrome (for example in antiphospholipid 
syndrome microhaemorrhages with linear 
and parallel disposition to capillaries bed 
are described); furthermore microhaemor-
rhages may be also post-traumatic and in 
the case of recent manicure misleading mi-
Figure 1 - Nailfold videocapillaroscopy images (x200) in healthy sub-
ject (A), Early (B), Active (C) and Late (D) patterns of scleroderma mi-
croangiopathy. 
No
n-
co
mm
er
ci
l u
s
 
ly
REVIEW
150 Reumatismo 4/2017
B. Ruaro, A. Sulli, V. Smith, et al.
crobleedings may be frequently observed) 
(1-3, 12).
The Late scleroderma NVC pattern shows 
an irregular enlargement of the capillaries, 
only a few or absence of giant capillaries 
and microhaemorrhages, severe capillary 
loss with avascular areas, disorganization 
of the normal capillary array and ramified/
bushy capillaries (Figure 1).
A scleroderma-like pattern may be ob-
served in SSc treated patients (several 
treatments may change the nailfold cap-
illary bed characteristics, either increas-
ing capillary number and neoangiogenic 
capillaries or reducing giant capillary and 
microhaemorrage number), as well as in 
connective tissue diseases other than SSc. 
The scleroderma-like pattern is defined as 
a capillary pattern with a mixture of the mi-
crovascular abnormalities included in the 
scleroderma capillary patterns, but one that 
does not fully fit the definition of any of the 
three aforementioned scleroderma patterns 
(1-3, 12). 
In 2008, Sulli et al. proposed to assess the 
NVC parameters belonging to the sclero-
derma pattern in a quantitative manner 
(enlarged capillaries, giant capillaries, mi-
crohaemorrhages, capillary loss, disorgani-
zation of the microvascular array and cap-
illary ramifications) (4, 8). To this aim, a 
semiquantitative rating scale to score these 
altered microvascular parameters was ad-
opted (4, 8). The capillary abnormalities 
were scored according to their intensity as 
follows: 0=no changes/reduction; 1=<33% 
of capillary changes/reduction; 2=33% 
to 66% of capillary changes/reduction; 
3=>66% of capillary changes/reduction. 
The average score for each capillaroscopic 
parameter was calculated from the analy-
sis of four consecutive fields (1 linear mm 
for each one) in the middle of the nailfold 
bed, on each digit. The average scores from 
the eight digits were then summed together 
and the final value was divided for eight 
fingers. The resulting value represented the 
score for each capillaroscopic parameter 
analyzed (4, 8). By convention, an abnor-
mal capillaroscopic finding is considered 
significant if it is observed in at least two 
of the subject’s fingers (2, 3, 15).
The microangiopathy evolution score 
(MES), made up of the sum of three pa-
rameter scores (capillary loss, disorganiza-
tion of the microvascular array and capil-
lary ramifications), was proposed to assess 
the progression of the vascular damage (4, 
8). An increase in the trend of these three 
alterations was observed during SSc pro-
gression, whilst giant capillaries and mi-
crohaemorrhages were not considered to 
be of critical value in assessing the evolu-
tion of the SSc microangiopathy, as these 
abnormalities are evident only in the early 
stages of the disease and then either disap-
pear or become rare in the more advanced 
stages (2, 3). The MES showed a statisti-
cally significant change throughout the 
follow-up, confirming its utility in quanti-
fying and monitoring the SSc microvascu-
lar damage (4, 8).
n	 CLINICAL APPLICATION OF 
NAILFOLD CAPILLAROSCOPY 
IN SYSTEMIC SCLEROSIS
Cross-sectional and predictive associa-
tions between progressive capillaroscopic 
changes (detecting microvascular damage) 
and clinical applications in SSc have re-
cently been described. One study described 
the association between progressive chang-
es in capillary morphology and disease 
subset and severity (23). Other studies that 
confirm the predictive role of capillaros-
copy for digital trophic lesions in SSc have 
been published (25, 26). Literature reports 
two single centre prospective studies that 
propose prognostic indices able to predict 
future progressive vascular disease in SSc 
patients on the basis of quantitatively as-
sessed hallmark parameters involved in 
the scleroderma pattern (i.e., capillary loss 
and/or giant capillaries) (25, 26). Smith et 
al. also demonstrated the role NVC plays 
in the prediction of both digital ulcers and 
organ involvement (27).
A recent international study (the CAP 
study) linking the nailfold capillaroscopic 
parameters to the progression of digital ul-
cers in SSc (700 patients, 14 Countries and 
59 Centres) has defined NVC analysis as a 
predictive tool (28). Moreover, Ricceri et 
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al. reported that NVC damage correlates 
with the grade of pulmonary arterial hyper-
tension (29, 30). 
Interestingly, NVC and related scores may 
also be used to monitor the effects of the 
therapies adopted in SSc treatment. How-
ever, to date there are only some pilot stud-
ies (no prospective, no randomized, no 
double blind and no placebo controlled) on 
this issue (31-43).
It has been observed that long term treat-
ment with the endothelin receptor antago-
nist bosentan, in combination with a vaso-
dilator (iloprost), in SSc patients affected 
by digital ulcers blocked the evolution of 
the microvascular damage after one year, 
as assessed by both NVC and peripheral 
blood flow analysis (37-40). Furthermore, 
some studies have made use of NVC to 
detect the response to immunosuppressive 
treatment for SSc severity outcome mea-
sures (41-43).
All of which led to NVC being included as 
a parameter in the 2001 LeRoy criteria for 
the classification of early systemic sclero-
sis (44). More recently, it was included in 
the 2013 VEDOSS criteria for very early 
diagnosis of SSc and in the new 2013 ACR/
EULAR classification criteria for SSc, and 
in 2014 diagnostic criteria for primary RP 
(45-47).
The use of capillaroscopy by physicians, in 
their routine clinical practice, was encour-
aged also by the authors of the 2013 ACR/
EULAR classification criteria for SSc (46). 
On the other hand, a recent multicentre in-
ternational study demonstrated that even 
the less skilled were able to use NVC to 
distinguish normal from abnormal capillar-
ies, after only one hour of training (48).
n	 CAPILLAROSCOPY LINKS 
TO LASER TECHNIQUES 
FOR THE ANALYSIS OF THE 
PERIPHERAL BLOOD FLOW
As previously mentioned, NVC is unable 
to measure the capillary blood flow/perfu-
sion under standard conditions, since only 
a morphological evaluation of the vas-
cular array can be performed (8). There-
fore, some studies have combined NVC 
to various other techniques able to assess 
and quantify cutaneous blood perfusion 
(numerous laser techniques, thermography 
and photoplethysmography) (49-56). 
Several studies have demonstrated that SSc 
patients have a lower peripheral blood flow 
than do both healthy subjects and primary 
RP patients, and that patients with the Late 
NVC pattern of microangiopathy have a 
lower blood flow at laser Doppler flowm-
etry (LDF) than patients with Active and 
Early NVC patterns (37, 40).
LDF is also efficacious in the evaluation of 
the variation in peripheral blood perfusion 
during treatment with vasodilator drugs 
within a few days, or even during a long 
follow-up (37, 40). However, one limit of 
the LDF technique is the possible site-to-
site variation (when moving the probe to 
evaluate the perfusion in different areas), 
limiting its efficacy in comparing blood 
flow between sites and in monitoring its 
change over time (37, 40, 53). 
However, laser Doppler imaging (LDI), 
which evaluates blood flow over a skin 
area, might well overcome this problem 
(49, 52). Murray et al. reported that NVC, 
LDI and thermal imaging (a technique that 
measures indirect blood flow) each inde-
pendently provide for a good discrimina-
tion between patients with SSc and those 
with primary RP and healthy controls. 
They observed that the combination of all 
three techniques improves the classifica-
tion of SSc patients and that LDI and ther-
mal imaging give equivalent information 
on dynamic changes in the cutaneous mi-
crocirculation. Moreover, they confirmed 
that NVC is the best method for classifying 
patient groups (49).
Rosato et al. used LDI and photoplethys-
mography (which uses infrared light to 
evaluate any changes in blood volume, and 
has been shown to have a positive concor-
dance with LDI) to study skin perfusion 
and digital artery pulsatility of the hands in 
patients with primary RP and SSc simulta-
neously. They demonstrated that, when the 
two tools are used together they are able to 
provide useful information in distinguish-
ing patients with primary RP from SSc 
patients, although NVC remains the best 
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method for analyzing microvascular dam-
age (52). 
The laser speckle contrast analysis (LAS-
CA), which measures skin perfusion using 
the speckle principle, has the advantage of 
being able to quantify blood perfusion over 
a large area and is a non-contact technique 
(53, 54). A recent study demonstrated that 
LASCA has a very good inter-rater reli-
ability for peripheral blood perfusion mea-
surements (55). Indeed, LASCA has been 
applied in research studies on RP and SSc 
(53, 54) and one such study demonstrated 
that peripheral blood perfusion evaluated 
by both LDF and LASCA correlates with 
the extent of the microangiopathy (53). 
It has also been reported that when patients 
with the Late SSc microangiopathy pattern 
were evaluated by both methods, a lower 
blood flow than that of patients with the 
Active or Early SSc patterns on NVC, was 
observed (Figure 2) (53). Another study, 
which used the LASCA technique for as-
sessment, reported that blood perfusion 
was significantly lower in SSc patients than 
in healthy subjects at the level of fingertips, 
periungual areas and palms of the hands 
and that there was a statistically significant 
negative correlation between the extent of 
the nailfold microangiopathy and the per-
fusion values at the level of the same skin 
areas in SSc patients (56). 
Another study demonstrated that LASCA 
is able to safely monitor digital ulcer evo-
lution in SSc patients, by evaluating the 
blood perfusion in different areas (sur-
rounding and within the skin lesions) dur-
ing standard treatment (57). A recent study 
has demonstrated that LASCA is also a 
good tool for evaluating the variation in 
peripheral blood perfusion during a long-
term follow-up (58).
Other techniques, such as thermal imaging, 
are able to make an indirect evaluation of 
blood perfusion, as they measure the skin 
temperature. Thermal imaging has been 
used in several studies to differentiate be-
tween primary RP and SSc. Distal dorsal 
difference >1°C between one or more fin-
gertips and the dorsum of the hand (fingers 
cooler) at +30°C seems predictive of a 
SSc-spectrum disorder (59). 
n	 CONCLUSIONS
There has been a rapid development of new 
methods with which to study microvascu-
lar damage in SSc patients over the last few 
years and these techniques have the advan-
tage of being non-invasive, safe, reproduc-
ible and quantifiable. Currently, NVC is 
the validated tool able to assess the micro-
vascular damage present in SSc patients in 
daily practice. Other complementary laser 
techniques have been used in pilot clinical 
research studies, demonstrating their use-
fulness for monitoring the effects of treat-
ments on skin blood perfusion, and need 
further validation.
Acknowledgments: the authors thank Bar-
bara Wade, contract Professor at the Uni-
versity of Torino, for her linguistic advice. 
The authors thank Doctor Sara De Grego-
rio from the Division of Rheumatology, 
University of Genova, for their support in 
graphic reproduction. Barbara Ruaro is 
supported by a Grant from the Italian Soci-
ety of Rheumatology 2015. All authors are 
members of the EULAR Study Group on 
Microcirculation in Rheumatic Diseases.
Conflict of interest: Maurizio Cutolo has 
received research funds from Actelion, 
BMS and Sanofi-Aventis.
Figure 2 - Laser speckle contrast analysis images of the hand dorsal 
aspect in a healthy subject (A) compared to a patient with a Late sclero-
derma pattern of microangiopathy (B). Blue = low blood perfusion; yel-
low = intermediate blood perfusion; red = high blood perfusion. 
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